Loading organizations...
Delaware Crossing Investor Group is an angel network providing capital and strategic counsel to early-stage and growth-oriented companies. They leverage a collective of experienced executives and entrepreneurs to offer both investment and crucial domain expertise, primarily targeting high-growth industries like information technology and life sciences. Their established investment strategy focuses on meticulously sourcing and funding promising ventures within the Mid-Atlantic region, extending beyond mere capital provision.
Founded in 2005, Delaware Crossing Investor Group emerged from the shared insight of a network of seasoned executives and entrepreneurs in the Greater Philadelphia area. This group recognized the pressing need for a structured angel investment platform that could deliver not only financial backing but also critical mentorship and industry-specific knowledge to nascent companies, thereby strengthening the regional startup ecosystem.
DCIG supports entrepreneurs seeking early-stage funding and strategic guidance, connecting them with its extensive network of seasoned investors. The organization's long-term vision centers on cultivating a robust and flourishing startup environment throughout the Mid-Atlantic region. They aim to bridge investor and entrepreneurial communities across the Delaware River, empowering innovative businesses for sustained growth and impact.
Key people at Delaware Crossing Investor Group.
Delaware Crossing Investor Group was founded in 2004 by Elizabeth Sigety (Managing Director & Co-Founder).
Key people at Delaware Crossing Investor Group.
Delaware Crossing Investor Group was founded in 2004 by Elizabeth Sigety (Managing Director & Co-Founder).
Delaware Crossing Investor Group has 4 tracked investments across 4 companies. The latest tracked deal is $540K Seed in ThruPore Technologies in February 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 21, 2018 | ThruPore Technologies | $540K Seed | Robin Hood Ventures | — |
| May 26, 2015 | Annovis Bio | $5.7M Series A | Michael Hoffman | Keiretsu Forum, Robin Hood Ventures |
| Jul 8, 2013 | Hulafrog | $500K Seed | Innovation Garden | Jumpstart NEW Jersey Angel Network |
| Jul 26, 2011 | Novira Therapeutics | $500K Seed | Delaware Crossing Investor Group, Karen Griffith Gryga, Gregory Harriman | Barbara S. Schilberg |